News
Erfolg International: Josef Penninger ist Österreicher des Jahres 2020
Aufgrund der aktuellen Corona-Situation konnten die Österreicherinnen und Österreicher des Jahres 2020 diesmal nicht im Rahmen der traditionellen Austria-Gala geehrt werden. So wurden die diesjährigen Preisträger im…
JLP screening technology supports development of promising first-in-class anti-cancer therapeutics.
In a study recently published in the journal Nature, scientists from Acus Laboratories GmbH (Acus) characterize a class of novel inhibitors of mitochondrial transcription (IMT).
Altered expression of mitochondrial…
Diet Research: Feast without gaining weight?
In a recent episode of Galileo, experts discuss molecular drivers of obesity and how we can control them to prevent overweight and associated diseases. Obesity is one of the major burdens of our society with huge impact on…
CCZ1, a promising roadblock for viral infections
Viruses are small infectious vehicles that enter human cells hijacking their machinery for replication. Marburg and Ebola viruses are two of the deadliest known viruses that can infect humans. Finding effective treatment…
Innovative Therapy for Glioblastoma Offers New Hope – Meet Us at AACR to Learn
JLP Health is developing a novel therapeutic approach for glioblastoma, aiming to initiate clinical trials by 2026. Leveraging its proprietary genetic screening platform, JLP Health has identified a promising combination…
New Press Releases
Press Release: Emerging Crimean-Congo Haemorrhagic Fever Virus: JLP Health Discovery Enables Novel Treatment Options
With the help of JLP Health’s screening technology, scientists discovered that impairing LDLR decreased disease symptoms in mice infected with CCHF virus. Vienna, Austria, 28th of March 2024 – A study published today in…
Press Release: Achilles heel of glioblastoma. JLP Health and its partners discover combinatorial treatment option for incurable brain tumors
By studying the mechanism of action from a widely used Nobel Prize winning anti-malaria drug named Artemisinin, the authors were able to pharmacologically sensitize brain cancer cells to this natural substance and…
Neue Wege zum Erfolg in der Krebs- und Virenforschung
Zwei bedeutende und international agierende Stiftungen aus dem Innviertel sind die neuen strategischen Partner der JLP Health GmbH. - JLP Health Press Release 4.5. 2021 (German)
JLP Health forscht gemeinsam mit renommierten Partnern an neuen Ansätzen zur Bekämpfung von COVID-19 und anderen tödlichen Viren.
Das Wiener Unternehmen JLP Health GmbH ist Teil eines hochkarätig besetzten Konsortiums, um neue antivirale Medikamente gegen SARS-CoV-2 herzustellen - JLP Health Press Release 7.10. 2020 (German)
Media
No news available.